Vericel Corporation (VCEL)
Vericel Corporation (VCEL) Tops Q4 Earnings Estimates
Vericel Corporation (VCEL) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.30 per share. This compares to earnings of $0.26 per share a year ago.
Vericel (VCEL) Is a Great Choice for 'Trend' Investors, Here's Why
Vericel (VCEL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Wednesday.
Vericel Corporation: Hard To Justify Current Valuation
Vericel Corporation, specializing in cellular therapies for sports medicine and severe burn care, has seen a 40% rise in its stock recently. Core products include MACI, NexoBrid, and Epicel, with Q3 revenues rising 27% year-over-year to $57.9 million, beating expectations. The company is turning the corner on profitability, but valuations look stretched at current trading levels.
Here's Why Momentum in Vericel (VCEL) Should Keep going
Vericel (VCEL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Vericel Corporation (VCEL) Q3 2024 Earnings Conference Call Transcript
MannKind Corporation (MNKD) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Eric Burns - Vice President of Finance & Investor Relations Nick Colangelo - Chief Executive Officer Joe Mara - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Richard Newitter - Truist Securities Mike Kratky - Leerink Partners Josh Jennings - TD Cowen Caitlin Cronin - Canaccord Jeffrey Cohen - Ladenburg Thalmann & Co. Operator Ladies and gentlemen, thank you for standing by. Welcome to Vericel's Third Quarter 2024 Conference Call.
Vericel Corporation (VCEL) Reports Q3 Loss, Tops Revenue Estimates
Vericel Corporation (VCEL) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.08 per share a year ago.
What Makes Vericel (VCEL) a New Strong Buy Stock
Vericel (VCEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Vericel Corporation (VCEL) Q2 2024 Earnings Call Transcript
Vericel Corporation (NASDAQ:VCEL ) Q2 2024 Results Conference Call August 1, 2024 8:30 AM ET Company Participants Eric Burns - Vice President of Finance & Investor Relations Nick Colangelo - Chief Executive Officer Joe Mara - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Mike Kratky - Leerink Partners Josh Jennings - TD Cowen Jeff Cohen - Ladenburg Thalmann & Company Swayampakula Ramakanth - HCW Operator Ladies and gentlemen, thank you for standing by. Welcome to Vericel's Second Quarter 2024 Conference Call.
Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates
Vericel Corporation (VCEL) came out with a quarterly loss of $0.10 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.11 per share a year ago.
